about
Plastids: The Green Frontiers for Vaccine ProductionPlant-based vaccines for animals and humans: recent advances in technology and clinical trialsPlant-produced candidate countermeasures against emerging and reemerging infections and bioterror agentsPlant-based solutions for veterinary immunotherapeutics and prophylacticsThe Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis BPurification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana.Disease Prevention: An Opportunity to Expand Edible Plant-Based Vaccines?Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations.Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge.Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.Hydrophobin fusion of an influenza virus hemagglutinin allows high transient expression in Nicotiana benthamiana, easy purification and immune response with neutralizing activity.How can plant genetic engineering contribute to cost-effective fish vaccine development for promoting sustainable aquaculture?A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge.Proteolysis of recombinant proteins in bioengineered plant cellsExpression of an immunogenic Ebola immune complex in Nicotiana benthamiana.Production of Japanese Encephalitis Virus Antigens in Plants Using Bamboo Mosaic Virus-Based VectorHuman papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in miceExpression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.Development of plant-produced protein body vaccine candidates for bluetongue virus.Plant Hsp90 proteins interact with B-cells and stimulate their proliferation.Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthPlant-based vaccines against viruses.Protection of recombinant mammalian antibodies from development-dependent proteolysis in leaves of Nicotiana benthamiana.Inhibition of human MCF-7 breast cancer cells and HT-29 colon cancer cells by rice-produced recombinant human insulin-like growth binding protein-3 (rhIGFBP-3).A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice.Boosting in planta production of antigens derived from the porcine reproductive and respiratory syndrome virus (PRRSV) and subsequent evaluation of their immunogenicity.Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate--Tackling the Cocktail ChallengeBioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations.Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine.A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses.Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 DiabetesImmunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum.A Genetically Modified Tobacco Mosaic Virus that can Produce Gold Nanoparticles from a Metal Salt Precursor.Stable plastid transformation for high-level recombinant protein expression: promises and challenges.Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamianaProduction of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells.Optimized Blanching Reduces the Host Cell Protein Content and Substantially Enhances the Recovery and Stability of Two Plant-Derived Malaria Vaccine Candidates.Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax.Design of virus-based nanomaterials for medicine, biotechnology, and energy.
P2860
Q26774629-FB258FD5-AD76-4DC4-918A-361686BAB27CQ26775788-B6403393-5971-428E-871C-5A545E180955Q26783107-336389A8-6ED2-4B31-87DB-C23D5F75E8C7Q27000876-077B0674-4493-44CA-B742-5057591F7E82Q28073401-E02E3E50-CC77-4C50-9931-69F250FA87AFQ30151541-1BD3030D-185A-45EC-AE9F-A8E6EE6FA5CDQ30234320-83BEF55F-0700-4E27-B1FE-9C601D803A1DQ30242080-3BD31607-D75E-452F-A8E8-C23BD8C982FAQ30357409-809D2635-C9EE-4540-B1F0-11664E1531FDQ30369470-D18398E3-311D-4127-B46F-57C2EB8D6874Q30370156-366A3075-2F67-40C5-A919-B1AB843798CEQ30393213-052EC04A-27AD-4161-BF1E-2F7166936EC4Q30425590-2250806F-0260-4853-B178-670134C0B996Q33560054-5E22CCF8-A2C5-48D5-B5F6-6B35C7D5687FQ33619065-A9655450-F9AC-4BF8-A800-E847C6C77E23Q33627913-C3EA5CF7-FC66-4DE9-890B-CA2220E94421Q33696617-C396EB0D-DD94-4AAE-B224-BB66D85B4875Q33723292-91D2E01E-6590-4DFA-A251-CFFAA6EF8462Q33743132-26B2C31F-5DD9-4681-9C4D-F1AF33F84448Q33942011-5108814A-5CC0-43BC-B93C-0E61F087F5B6Q34497705-31C89E66-58C1-4E33-9EA6-DEF062357D7BQ34687464-0CD15E84-BA5A-4A01-B01A-9E816D5ACFEAQ34875756-23444181-77CB-4CDE-A6E7-3FF8341FA03CQ35021773-6B604334-2301-4D53-873E-3A5C8620F1C0Q35048518-D0EF33A0-F21A-4B53-AA5E-38891ACF6124Q35116494-D09FA9E3-C4A9-47C2-B7D3-DCD63E39385AQ35683366-E6C43701-55F4-4E0E-9BC2-DB4140A6A622Q35754185-541F51A9-E5C1-4350-94A7-376F2C86B0BEQ35887003-E8A03384-19F9-43CD-81AA-25971A31C4E6Q35887438-CD2A9238-C9E8-4188-A6CC-01E0C3AFD6E7Q35897441-8F488BEE-67F7-4940-8A5F-7B93991EF623Q35960908-D6DFD6D6-4D88-4537-B5CE-7EDFAC4A504EQ35996281-976605F7-64A5-46E8-A7EB-7D7AA979EE14Q36265635-82B0CCDA-A40B-4106-BD10-31BEBB06423EQ36327788-C2B44D15-9BB5-4822-BDEB-391E8B6406B8Q36340900-FB5EE333-4BF6-4D8C-9073-6B61123AD504Q36555514-8D2D30E3-568B-45CA-ACE4-35E6E49AC6BAQ36587356-5AFA881B-98A5-44D3-A4D6-804DBAE6F22DQ37025716-1E2A1944-D91B-4511-8B3B-4F7A41EFFB40Q37346447-96C72D9A-ECDF-4552-BF38-7B0439AACB98
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Plant-made vaccines for humans and animals.
@ast
Plant-made vaccines for humans and animals.
@en
type
label
Plant-made vaccines for humans and animals.
@ast
Plant-made vaccines for humans and animals.
@en
prefLabel
Plant-made vaccines for humans and animals.
@ast
Plant-made vaccines for humans and animals.
@en
P2860
P1476
Plant-made vaccines for humans and animals.
@en
P2860
P304
P356
10.1111/J.1467-7652.2010.00507.X
P577
2010-03-11T00:00:00Z